Chemistry tools are getting faster than the experts who tune them

What changed

A set of preprints posted this week takes aim at the slow parts of chemistry work, and each one reports its gain as a measured comparison rather than a promise. The common thread is automation replacing hand tuning, hand viewing and hand synthesis, step by step, across the workflow a chemist or a lab automation team actually runs. m:…6537 m:…7465 m:…7464 m:…8149

Start with calibration. Bayesian Optimization of Indirect Hard Modeling, a method for quantitative spectral analysis, achieved up to 50% reduction in cumulative cross-validation RMSE compared with expert-selected models, and up to 60% reduction in cumulative prediction RMSE compared with expert-selected models. The optimization can be performed in approximately five hours or less on standard desktop hardware, which matters because the alternative is an expert spending their time tuning the same settings by hand. m:…6537

Then viewing. CueMol3 achieves a frame rate of nearly 60 fps for the visualization of 2.44 million atoms, and it outperforms Mol* and VMD in frame rates for large molecular dynamics trajectories ranging from 0.35 to 3.9 million atoms. The tool does this with a C++ computational engine embedded as a Node.js native addon to write geometry directly into WebGL2 buffers without JavaScript-side copying, which is the kind of plumbing detail that decides whether a huge trajectory is viewable at all or just a file that crashes the viewer. m:…7465

Then matching. ROSHAMBO3 achieves a 78-154x speedup over the previous open state of the art, ROSHAMBO2, and supports throughput of up to 55M query-conformer pairs/s on NVIDIA GPUs. It uses query-amortized Gaussian fields to achieve linear-time complexity in the inner loop of shape alignment, replacing the quadratic inner loops that made large virtual screens slow. Shape similarity is a basic building block of virtual screening and molecular machine learning, so a faster primitive compounds across every screen that uses it. m:…7464

Then making. AutoSPS-D2B enables multistep, resin-bound chemistry for direct-to-biology screening, and the workflow allows for the rapid sampling of over 1,700 building block combinations. Applied to CCR2 ligands, it resulted in a six-fold binding affinity improvement within two DMTA cycles. The point of direct-to-biology screening is to test crude libraries without purifying every compound beforehand, and expanding the reaction scope of that approach means more kinds of chemistry can go straight from synthesis to assay. m:…8149

Why speed is the story

None of these preprints claims a new molecule or a new reaction. What they claim is that the existing work gets done faster, more accurately, or at a scale the old tools could not reach. That is a different kind of progress, and it is easy to underrate. A calibration that finishes in approximately five hours or less on standard desktop hardware does not need a specialist to babysit it, which lowers the barrier for a lab that wants quantitative spectral analysis without hiring for it. m:…6537

The visualization and shape-matching gains point the same way. When CueMol3 holds nearly 60 fps on 2.44 million atoms, a researcher can explore a large trajectory interactively instead of waiting on still images. When ROSHAMBO3 reaches up to 55M query-conformer pairs/s on NVIDIA GPUs, a screening run that was a batch job becomes something closer to an interactive query. The implication is that the bottleneck in computational chemistry shifts from raw compute to asking better questions, because the tools stop being the thing you wait for. m:…7465 m:…7464

AutoSPS-D2B closes the loop on the physical side. Sampling over 1,700 building block combinations and improving binding affinity six-fold within two DMTA cycles is a concrete demonstration that automated solid-phase synthesis can feed direct-to-biology screening with more complex chemistry than solution-phase methods allowed. For a team running a hit-to-lead programme, the practical question is how many more ideas can be tested per cycle, and this preprint answers with a number rather than an aspiration. m:…8149

What to watch before trusting it

All of this is preprint work, not peer-reviewed, and each result is reported by its own authors on their own tests. The Bayesian Optimization gains are measured against expert-selected models on the spectroscopic models the authors built, so the natural question is whether the same tuning advantage holds on a different instrument or a different sample set. The CueMol3 and ROSHAMBO3 numbers are performance figures on large trajectories and on NVIDIA GPUs, so a lab running different hardware or smaller systems may see a different gain. m:…6537 m:…7465 m:…7464

AutoSPS-D2B is demonstrated on CCR2 ligands, with a six-fold binding affinity improvement within two DMTA cycles. That is a strong demonstration, not a guarantee that the same workflow improves every target by the same amount. The honest read is that automation across the chemistry workflow is advancing on several fronts at once, and the next test is whether independent labs reproduce these gains on their own problems rather than the authors' chosen examples. m:…8149